甘草化合物在口颌面部疾病治疗中的研究进展

doi:10.3969/j.issn.1005-4979.2022.04.010

《口腔颌面外科杂志》 ›› 2022, Vol. 32 ›› Issue (4): 254-256. doi: 10.3969/j.issn.1005-4979.2022.04.010

甘草化合物在口颌面部疾病治疗中的研究进展

翦新春¹^,³^,⁴(), 翦羽², 潘文翔³^,⁴, 高兴¹, 凡任飞³^,⁴, 康宗华³, 匡凤军³

¹ 中南大学湘雅医院口腔颌面外科, 2. 妇产科，湖南长沙 410008
³ 湘琼中亚健康槟榔研究院，湖南长沙 410000
⁴ 开福振亚口腔医学部，湖南长沙 410000

收稿日期:2021-11-09 修回日期:2022-01-09 出版日期:2022-08-28 发布日期:2022-08-29
通讯作者: 翦新春，教授. E-mail: drjianxinchun@163.com
作者简介:
翦新春（1951—），男，湖南人，硕士，教授

Recent advances of licorice compounds in the treatment of oral and maxillofacial diseases

JIAN Xinchun¹^,³^,⁴(), JIAN Yu², PAN Wenxiang³^,⁴, GAO Xing¹, FAN Renfei³^,⁴, KANG Zonghua³, KUANG Fengjun³

¹ Department of Oral and Maxillofacial Surgery, 2. Department of Obstetrics and Gynecology,Xiangya Hospital, Central South University, Changsha 410008, Hunan Province
³ Institute of Health Areca of Hunan and Hainan Zhongya, Changsha 410000, Hunan Province
⁴ Zhen Ya Clinic of Stomatology, Changsha 410000, Hunan Province, China

Received:2021-11-09 Revised:2022-01-09 Online:2022-08-28 Published:2022-08-29

摘要/Abstract

摘要：

甘草是一种被广泛用于治疗疾病的中药，并且具有良好的治疗效果。近些年来，甘草化合物被用来治疗口腔黏膜、颌面颈部炎症及肿瘤，取得了一定的疗效。本文对甘草化合物治疗口颌面部疾病的研究进展进行综述。

关键词: 甘草, 甘草化合物, 口腔黏膜病, 口腔颌面部

Abstract:

Licorice is a traditional medicine that has been widely used in our country to treat diseases with good therapeutic effects. Recently, licorice compounds have been used to treat diseases of oral mucosa, maxillofacial and neck inflammatory diseases, and tumors，and also achieved promising curative effects. This article reviews the research advances of licorice compounds in the treatment of oral and maxillofacial diseases.

Key words: licorice, compounds of licorice, oral mucosal disease, oral and maxillofacial region

中图分类号:

R782

翦新春, 翦羽, 潘文翔, 高兴, 凡任飞, 康宗华, 匡凤军. 甘草化合物在口颌面部疾病治疗中的研究进展[J]. 《口腔颌面外科杂志》, 2022, 32(4): 254-256.

JIAN Xinchun, JIAN Yu, PAN Wenxiang, GAO Xing, FAN Renfei, KANG Zonghua, KUANG Fengjun. Recent advances of licorice compounds in the treatment of oral and maxillofacial diseases[J]. 《Journal of Oral and Maxillofacial Surgery》, 2022, 32(4): 254-256.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2022/V32/I4/254

参考文献 18

[1]	Chen YY, Cao YJ, Tang YP, et al. Comparative pharmacodynamic, pharmacokinetic and tissue distribution of Dahuang-Gancao Decoction in normal and experimental constipation mice[J]. Chin J Nat Med, 2019, 17(11): 871-880.
[2]	Shen XF, Li L, Ma QH, et al. Pharmacokinetic study of eight bioactive components following oral administration of Zhiqiao Gancao Decoction and observation of its clinical efficacy[J]. Biomed Chromatogr, 2020, 34(2): e4706. doi: 10.1002/bmc.v34.2 URL
[3]	李葆林, 麻景梅, 田宇柔, 等. 甘草中新发现化学成分和药理作用的研究进展[J]. 中草药, 2021, 52(8): 2438-2448.
[4]	Chen XY, Yang M, Hao WJ, et al. Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq[J]. Gene, 2016, 592(1): 86-98. doi: S0378-1119(16)30589-3 pmid: 27461947
[5]	Xiang SJ, Chen HJ, Luo XJ, et al. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling[J]. J Exp Clin Cancer Res, 2018, 37(1): 184. doi: 10.1186/s13046-018-0844-x pmid: 30081934
[6]	Zhang XY, Zhao SW, Song XB, et al. Inhibition effect of Glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition[J]. J Pharmacol Sci, 2018, 137(4): 324-332. doi: S1347-8613(18)30059-8 pmid: 30150145
[7]	Hou CL, Li WG, Li ZY, et al. Synthetic isoliquiritigenin inhibits human tongue squamous carcinoma cells through its antioxidant mechanism[J]. Oxid Med Cell Longev, 2017, 2017: 1379430.
[8]	Xiang C, Qiao X, Ye M, et al. Classification and distribution analysis of components in Glycyrrhiza using licorice compounds database[J]. Yao Xue Xue Bao, 2012, 47(8): 1023-1030.
[9]	李葆林, 麻景梅, 田宇柔, 等. 甘草中新发现化学成分和药理作用的研究进展[J]. 中草药, 2021, 52(8): 2438-2448.
[10]	Wang JR, Li TZ, Wang C, et al. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway[J]. Naunyn Schmiedeberg's Arch Pharmacol, 2020, 393(10): 1987-1999. doi: 10.1007/s00210-019-01763-7
[11]	Wang JR, Luo YH, Piao XJ, et al. Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK/STAT3/NF-κB pathways in human hepatocellular carcinoma cells[J]. Drug Dev Res, 2019, 80(4): 461-470. doi: 10.1002/ddr.v80.4 URL
[12]	Wu CH, Chen HY, Wang CW, et al. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice[J]. Oncotarget, 2016, 7(45): 73432-73447. doi: 10.18632/oncotarget.v7i45 URL
[13]	杨剑, 韩立峰, 邵睿, 等. 中成药抑制成纤维细胞胶原沉积的作用研究[J]. 天津中医药, 2020, 37(6): 618-622.
[14]	Huang XY, He YC, Chen YF, et al. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway[J]. BMC Pulm Med, 2016, 16(1): 132. pmid: 27658704
[15]	肖益彩, 翦新春, 郑廉, 等. 口腔黏膜下纤维性变病损黏膜下曲安奈德联合丹参酮液注射方法及疗效探讨[J]. 上海口腔医学, 2017, 26(2): 188-192.
[16]	陆璨, 翦新春. 曲安萘德联合丹参酮液治疗软腭黏膜下纤维性变的疗效评价[J]. 中南大学学报(医学版), 2019, 44(7): 801-804.
[17]	翦新春, 郑廉, 朱蓉, 等. 曲安奈德和丹参酮注射液治疗口腔黏膜下纤维化的效果评价[J]. 中华口腔医学杂志, 2017, 52 (1): 16-21.
[18]	翦新春, 高兴. 口腔黏膜下纤维性变的病因、致病机理、诊断与治疗[J]. 口腔疾病防治, 2021, 29(4): 217-225. doi: 10.12016/j.issn.2096-1456.2021.04.001

选择文件类型/文献管理软件名称

选择包含的内容

甘草化合物在口颌面部疾病治疗中的研究进展

Recent advances of licorice compounds in the treatment of oral and maxillofacial diseases

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献 18

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨毅璇, 羊正林, 杨森, 郭丽娟. 颏部软组织黏液瘤1例并文献复习[J]. 《口腔颌面外科杂志》, 2023, 33(3): 198-201.
[2]	朱东飞, 胡倩, 刘泽文. 老年口腔颌面部恶性肿瘤患者术后应激性消化道溃疡出血的高危因素分析[J]. 《口腔颌面外科杂志》, 2022, 32(2): 106-109.
[3]	唐圣斌, 李琴, 雷邓. 口腔颌面部间隙感染患者预后不良的影响因素分析[J]. 《口腔颌面外科杂志》, 2022, 32(1): 46-50.
[4]	张帅源，付昊杰，秦硕，李光辉，易雅群，孙明磊. 口腔颌面部恶性肿瘤外周血循环肿瘤细胞检测及其临床意义[J]. 《口腔颌面外科杂志》, 2021, 31(6): 349-.
[5]	邓可晗，李静，姜采弟，窦文雪，陈海文，汪大林. 口腔颌面部火器伤机制及创伤救治[J]. 《口腔颌面外科杂志》, 2021, 31(5): 327-.
[6]	石海波，项丹威，叶佳朋，吴春月，宋丽娜，刘麒麟. 颏下岛状瓣在口腔颌面部恶性肿瘤切除术后修复中的应用[J]. 《口腔颌面外科杂志》, 2021, 31(4): 221-.
[7]	陈浩，陈伦秋，欧阳可雄，李智聪，涂子君，朴正国. 口腔颌面部梭形细胞瘤1例[J]. 《口腔颌面外科杂志》, 2021, 31(3): 193-.
[8]	张铭，梁晓伟，吴更. 股前外侧皮瓣携带肌瓣和/或脂肪瓣在口腔颌面部缺损重建中的应用[J]. 《口腔颌面外科杂志》, 2021, 31(1): 32-36.
[9]	黄芳芳1，2，田玲3，韦倩1，2，周诺1，2. 第三磨牙来源的口腔颌面部间隙感染危险因素分析[J]. 《口腔颌面外科杂志》, 2020, 30(4): 234-.
[10]	韩生伟, 韩伟, 孙国文, 王志勇, 胡勤刚. 口腔颌面部恶性周围神经鞘膜瘤：3例报告及文献复习[J]. 《口腔颌面外科杂志》, 2019, 29(2): 114-117.
[11]	郭建1, 蒋子超2, 冯晓东3. 胸大肌肌皮瓣在口腔颌面部恶性肿瘤术后缺损修复中的应用[J]. 《口腔颌面外科杂志》, 2017, 27(4): 282-284.
[12]	王晔，汪饶饶. 口腔颌面部恶性神经鞘瘤的影像学和病理学分析[J]. 《口腔颌面外科杂志》, 2015, 25(5): 360-.
[13]	彭布强，高振杰，陈献礼，申露露. 下颌下腺神经内分泌癌1例报告并文献回顾[J]. 《口腔颌面外科杂志》, 2015, 25(3): 237-.
[14]	夏超，谭颖徽. 影响上蒂垂直型颈阔肌肌皮瓣成活因素的临床分析[J]. 《口腔颌面外科杂志》, 2014, 24(3): 195-.
[15]	郑凌艳1，张伟杰1，杨驰1，蔡协艺1，姜滨1，王保利1，浦益萍1，金佳敏1，厉婕嫣1，管丹萍2. 口腔颌面部多间隙感染老年患者与中青年患者的临床比较[J]. 《口腔颌面外科杂志》, 2013, 23(5): 364-368.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

甘草化合物在口颌面部疾病治疗中的研究进展

Recent advances of licorice compounds in the treatment of oral and maxillofacial diseases

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献 18

相关文章 15

编辑推荐

Metrics

本文评价